Peter Ruppersberg

Dr. Peter Ruppersberg is a senior executive with over 15 years of international experience in technology product strategy, medical marketing, business development, and finance. He was most recently the CEO of the Valtronic Group, a Geneva, Switzerland-based firm with 400 employees specializing in “mechatronics” manufacturing solutions with a focus on medical device manufacturing. Previously, he was also active in venture capital and private equity. At the University of Tuebingen, Dr. Ruppersberg served as the Chairman of Physiology and Director of the Hearing Research Center. Dr. Ruppersberg began his career as an Assistant Professor at the Max-Planck Institute for Medical Research.

Dr. Ruppersberg holds an M.D. from the University of Ulm, Germany, and a Habilitation in Biophysics and Physiology.

Peter Ruppersberg is the Chief Scientific Officer & President at Ablacon, based in Switzerland, Europe. With a background in Artificial Intelligence (AI), Peter Ruppersberg has a rich history of leadership and innovation.Peter Ruppersberg studied MD unknown at University of Ulm. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.